ACCANIS BIOTECH F&E GMBH & CO KG has a total of 15 patent applications. It increased the IP activity by 1300.0%. Its first patent ever was published in 2017. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are VIRTTU BIOLOGICS LTD, BIOXCEL THERAPEUTICS INC and ZHUHAI ESSEX BIO PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | Republic of Korea | 2 | |
#6 | United States | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Mattner Frank | 15 |
#2 | Schmidt Walter | 15 |
#3 | Mandler Markus | 15 |
#4 | Schneeberger Achim | 15 |
Publication | Filing date | Title |
---|---|---|
US2020038487A1 | Prevention and treatment of non-melanoma skin cancer (nmsc) | |
EP3437650A1 | Treatment of local skin hypotrophy conditions |